(2007) „The CD14+ CD16+ Blood Monocytes: their Role in Infection and Inflammation, Review”. J Leukocyte Biology81 (3), 584–92. o. DOI:10.1189/jlb.0806510. PMID17135573.
(2013) „Monocytes in Coronary Artery Disease and Atherosclerosis. Where are we now?”. Journal of the American College of Cardiology62, 1541–1551. o. DOI:10.1016/j.jacc.2013.07.043. PMID23973684.
(2012) „CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography”. J Am Coll Cardiol60 (16), 1512–1520. o. DOI:10.1016/j.jacc.2012.07.019.
(1996) „Stimulating properties of 5-oxo-eicosanoids for human monocytes: Synergism with monocyte chemotactic protein-1 and -3”. Journal of immunology (Baltimore, Md. : 1950)157 (10), 4664–71. o. PMID8906847.
(2007) „The CD14+ CD16+ Blood Monocytes: their Role in Infection and Inflammation, Review”. J Leukocyte Biology81 (3), 584–92. o. DOI:10.1189/jlb.0806510. PMID17135573.
(2013) „Monocytes in Coronary Artery Disease and Atherosclerosis. Where are we now?”. Journal of the American College of Cardiology62, 1541–1551. o. DOI:10.1016/j.jacc.2013.07.043. PMID23973684.